Generate a tailored SOP for Dr. Carsten Schmitz Peiffer. Improve your application with a focused, well-structured draft.
Carsten Schmitz-Peiffer is a Conjoint Associate Professor in the School of Clinical Medicine at the University of New South Wales. He completed his PhD in Biochemistry at the University of Bristol, UK, under Professor Dick Denton, where he studied insulin signal transduction and fat cell metabolism. He later joined the Garvan Institute, focusing on how lipid oversupply disrupts normal insulin action. His research has identified a clear link between protein kinase C activation and insulin resistance in skeletal muscle caused by lipid-induced factors. Schmitz-Peiffer's work utilizes animal models of insulin resistance along with proteomic and lipidomic approaches to explore the underlying molecular mechanisms of defective insulin action observed in obesity and Type 2 diabetes. He has published extensively on the roles of specific protein kinases in glucose and lipid metabolism and continues to investigate innovative strategies for diabetes therapies.
University of New South Wales • Sydney, NSW, Australia
Teaching and conducting research focused on insulin resistance, lipid metabolism, and diabetes.
Garvan Institute • Sydney, NSW, Australia
Investigating molecular mechanisms of insulin action and exploring diabetes treatment strategies.
Includes Business Intelligence, Enterprise Systems, and Cybersecurity Management streams.